Renasant Corporation
NYSE:RNSTBanks - Regional
+$0.46 today
- Market cap
- $3.58B
- Beta
- 0.99
- P/E (TTM)
- 17.1
- EPS (TTM)
- $2.43
- Dividend yield
- 2.21%
Volume 0.75M
Average 0.69M
RNST Sales of Investments
Cash received from selling or redeeming investments.
Renasant CorporationNYSE: RNST
Sales of Investments · Q2 FY2026 · quarter ended Jun 2026
Sales of investments declines year over year
Q2 FY2026 sales of investments of $174.79M fell 78.0% year over year, behind the -34.8% change in trailing-twelve-month sales of investments. Sequentially, it rose 23.6% from the prior quarter. Over 3 fiscal years it compounded at +34.4% a year.
Context
- Sales of investments amounted to 76.2% of revenue in FY2025, up 40.7 pp from a year earlier.
- Sales of investments increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -78.0% toward the trailing-twelve-month pace of -34.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Sales of Investments history
USD · from the cash flow
- Latest · FY2025
- 1.1B USD
- Year-over-year change
- +198.7%
- 4-year CAGR
- +14.6%
| Period | Period end | Sales of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.1B | +198.7% |
| FY2024 | 2024-12-31 | 368.19M | -50.8% |
| FY2023 | 2023-12-31 | 747.96M | +65.1% |
| FY2022 | 2022-12-31 | 452.96M | -28.9% |
| FY2021 | 2021-12-31 | 636.72M | — |
Sales of Investments vs competitors
How RNST compares with its peers on the latest reported figures
- RNST's LTM Jun 2026 sales of investments of $619.29M is the 8th largest of the 11 companies compared; the peer median is $1.28B.
- Its year-over-year change of -34.8% is the 9th highest of 11, against a peer median of +11.5%.
- Sales of investments amounts to 49.6% of revenue for RNST, versus a peer median of 80.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $4.87B | +33.0% | +12.0% | 260.8% | |
| LTM Jun 2026 | $2.68B | +3.3% | +18.4% | 104.5% | |
| LTM Jun 2026 | $2.35B | +77.0% | +51.2% | 185.6% | |
| LTM Jun 2026 | $1.65B | +19.7% | -8.9% | 172.7% | |
| LTM Jun 2026 | $1.39B | -10.1% | +98.4% | 100.2% | |
| LTM Jun 2026 | $1.17B | +91.2% | -1.9% | 61.2% | |
| LTM Jun 2026 | $1.13B | -55.1% | +3.4% | 25.8% | |
| LTM Jun 2026 | $619.29M | -34.8% | +34.4% | 49.6% | |
| LTM Jun 2026 | $563.1M | +46.5% | +16.9% | 44.9% | |
| LTM Jun 2026 | $341.24M | -63.7% | -18.4% | 35.0% | |
| LTM Jun 2026 | $82.91M | -18.2% | -29.2% | 7.9% | |
| Peer median (excluding RNST) | $1.28B | +11.5% | +7.7% | 80.7% | |
Competitors are the stored peer set for RNST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 175.89M | 166.07M | 144.68M | 195.46M | 181.27M |
| Depreciation & Amortization | 47.35M | 42.74M | 35.23M | 32.28M | 16.21M |
| Deferred Income Tax | 11.41M | 2.28M | (5.01M) | 4.65M | 1.69M |
| Stock-Based Compensation | 10.07M | 11.51M | 13.72M | 13.88M | 17.72M |
| Change in Working Capital | (63.73M) | (35.95M) | (27.99M) | (22.87M) | (18.07M) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | (63.73M) | (35.95M) | (27.99M) | (22.87M) | (18.07M) |
| Other Non-Cash Items | (38.34M) | 387.4M | (12.08M) | (93.98M) | 72.65M |
| Operating Cash Flow | 142.66M | 574.05M | 148.55M | 129.43M | 271.47M |
| Capital Expenditures | (20.52M) | (14.84M) | (21.63M) | (13.65M) | (33.72M) |
| Acquisitions (Net) | 0 | (120.89M) | 0 | 55.33M | 267.9M |
| Purchases of Investments | (2.16B) | (804.9M) | (11.9M) | (174.23M) | (1.2B) |
| Sales of Investments | 636.72M | 452.96M | 747.96M | 368.19M | 1.1B |
| Other Investing Activities | 883.86M | (1.56B) | (769.83M) | (533.69M) | (866.94M) |
| Investing Cash Flow | (660M) | (2.04B) | (55.4M) | (298.04M) | (734.03M) |
| Debt Repayment | (13.21M) | 636.39M | (407.34M) | (199.8M) | 89.51M |
| Common Stock Issued | 0 | 0 | 0 | 217M | 0 |
| Common Stock Repurchased | (21.32M) | 0 | 0 | 0 | (13.34M) |
| Dividends Paid | (50.02M) | (49.99M) | (50.28M) | (53.73M) | (78.6M) |
| Other Financing Activities | 1.85B | (418.76M) | 589.82M | 495.83M | 443.67M |
| Financing Cash Flow | 1.76B | 167.64M | 132.21M | 459.3M | 441.24M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 1.24B | (1.3B) | 225.36M | 290.68M | (21.31M) |
| Free Cash Flow | 122.14M | 559.21M | 126.92M | 115.78M | 237.75M |
Renasant Corporation
NYSE:RNST
Intrinsic Alpha fair value
Locked
Current Price
$39.68
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.